Health Canada reviewing safety of drospirenone-containing oral contraceptives Yasmin and Yaz and risk of venous thromboembolism Health products. Report a problem or mistake on this page What was wrong? I can't find the information. The information is hard to understand. There was an error or something did not work. Other reason. Please provide more details.
You will not receive a reply. Telephone numbers and e-mail addresses will be removed. Date modified: In December , two FDA advisory committees were convened to review the safety problems with Yaz and Yasmin , and to evaluate whether the birth control pills should remain on the market. The panel narrowly voted against recommending a recall for Yaz and Yasmin, voting that the benefits outweigh the health risks. However, the panel voted to add new blood clot warnings, indicating that the prior Yaz and Yasmin labels were vague and confusing.
In April , the FDA announced updated warning labels for Yaz, Yasmin and other drospirenone-based birth control pills. The new label warnings point out that some studies report side effects of the birth control pills may triple the risk of blood clots when compared to pills containing other progestins, but notes that some studies have found no increased risk. This page is maintained for informational purposes only.
Provide contact information below and additional private comments if you want an attorney to contact you to review a potential case. In Germany alone, 6. Taken correctly, the pill is over 99 percent effective at preventing pregnancy. But with some brands of the contraceptive pill comes the risk of potentially deadly side effects. On Thursday, a court case against German pharmaceutical giant Bayer will open in the southern German town of Waldshut-Tiengen.
The law suit was first filed in May by German native Felicitas Rohrer. The year-old claims she suffered a double pulmonary embolism as a result of taking Bayer's Yasminelle contraceptive pill, which uses the hormone drospirenone. An embolism is caused by a blot clot obstructing the circulatory system. In , Rohrer, who was 25 at the time, suddenly collapsed and her heart stopped beating for 20 minutes. In emergency open-heart surgery, doctors found huge blood clots blocking the main artery to her lung.
I've never smoked, I'm not overweight and I've always exercised," Rohrer wrote on her website. After finding no alternative explanation, doctors pointed the finger at Bayer's pill, which Rohrer had been taking for eight months when she collapsed.
Since her surgery six years ago, Rohrer has had to take an anti-coagulant which reduces her chances of conceiving a child. Rohrer's case will be the first of its kind in Germany, but in the US, such lawsuits are far from unheard of. In alone, the company paid out million euros in cases connected with with its Yasmin contraception range, which includes Yaz, Yasmin and Yasminelle.
According to several recent studies, birth control pills containing drospirenone, such as Bayer's Yasmin range or Jenapharm's Aida and Petibelle, were found to increase the risk of an embolism or thrombosis by up to three times compared to previous generations of contraceptive pill.
Researchers in a study that assessed the data of 1. Germany's Federal Institute for Drugs and Medical Devices BfArM also said they received reports from women in the last 15 years who suffered from thrombosis and were also taking a contraceptive pill containing drospirenone. Sixteen of the suspected cases resulted in death. Despite the studies, Bayer insists that its contraceptive pills are safe when taken correctly.
0コメント